These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 17633567

  • 1. Use and long-term outcome of bare metal stent implantation in the drug-eluting stent era.
    Fujimoto H, Dohi T, Masuda J, Mitani H, Fujimoto Y, Maehara A, Nishiyama S, Nakanishi S, Yamaguchi T, Ishiwata S, Ohno M.
    J Cardiol; 2007 Jun; 49(6):305-12. PubMed ID: 17633567
    [Abstract] [Full Text] [Related]

  • 2. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M, Gori T, Pierli C, Casini S, Sinicropi G, Buti A, Del Pasqua A, Bravi A.
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [Abstract] [Full Text] [Related]

  • 3. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L, Chen LL, Lin CG, Peng YF, Zheng XC, Luo YK, Zhang FL, Chen JH, Yan XP, Huang ZR.
    Chin Med J (Engl); 2008 Aug 20; 121(16):1518-23. PubMed ID: 18982862
    [Abstract] [Full Text] [Related]

  • 4. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, Schofer J, Morice MC, Schampaert E, Kirtane AJ, Popma JJ, Parise H, Fahy M, Mehran R.
    J Am Coll Cardiol; 2009 Sep 01; 54(10):894-902. PubMed ID: 19712798
    [Abstract] [Full Text] [Related]

  • 5. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions.
    Kim YH, Park SW, Lee CW, Hong MK, Gwon HC, Jang Y, Lee MM, Koo BK, Oh DJ, Seung KB, Tahk SJ, Yoon J, Park SJ.
    Catheter Cardiovasc Interv; 2006 Feb 01; 67(2):181-7. PubMed ID: 16400663
    [Abstract] [Full Text] [Related]

  • 6. Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation.
    Jeong YH, Hong MK, Lee CW, Park DW, Kim YH, Kim JJ, Park SW, Park SJ.
    Int J Cardiol; 2008 Mar 28; 125(1):36-40. PubMed ID: 17521753
    [Abstract] [Full Text] [Related]

  • 7. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C, Kim SH, Suh J, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Park SJ.
    Catheter Cardiovasc Interv; 2008 Apr 01; 71(5):594-8. PubMed ID: 18311841
    [Abstract] [Full Text] [Related]

  • 8. Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: results of Korean multicenter angioplasty team (KOMATE) Registry.
    Kim BK, Oh S, Jeon DW, Yang JY, Kim JS, Park S, Choi D, Jang Y, Hong BK, Kwon HM, Lee SW, Goh CW, Kwon K, Ryu SK, Korean Multicenter Angioplasty Team (KOMATE) Investigators.
    J Interv Cardiol; 2009 Oct 01; 22(5):411-9. PubMed ID: 19702679
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial.
    Kelbaek H, Kløvgaard L, Helqvist S, Lassen JF, Krusell LR, Engstrøm T, Bøtker HE, Jørgensen E, Saunamäki K, Aljabbari S, Thayssen P, Galløe A, Jensen GV, Thuesen L.
    J Am Coll Cardiol; 2008 May 27; 51(21):2011-6. PubMed ID: 18498953
    [Abstract] [Full Text] [Related]

  • 10. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
    Jiménez-Quevedo P, Sabaté M, Angiolillo DJ, Alfonso F, Hernández-Antolín R, SanMartín M, Gómez-Hospital JA, Bañuelos C, Escaned J, Moreno R, Fernández C, Fernández-Avilés F, Macaya C, DIABETES Investigators.
    Eur Heart J; 2007 Aug 27; 28(16):1946-52. PubMed ID: 17562666
    [Abstract] [Full Text] [Related]

  • 11. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B, Li JJ, Yang YJ, Ma WH, Chen JL, Qiao SB, Qin XW, Yao M, Liu HB, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Xia R, Gao RL.
    Chin Med J (Engl); 2006 Apr 05; 119(7):533-8. PubMed ID: 16620692
    [Abstract] [Full Text] [Related]

  • 12. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
    Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Bruining N, Van den Branden F, Van Langenhove G.
    J Am Coll Cardiol; 2006 Dec 19; 48(12):2423-31. PubMed ID: 17174178
    [Abstract] [Full Text] [Related]

  • 13. Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease.
    Barlis P, Kaplan S, Dimopoulos K, Ferrante G, Di Mario C.
    Cardiology; 2008 Dec 19; 111(4):270-6. PubMed ID: 18451644
    [Abstract] [Full Text] [Related]

  • 14. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S, Burzotta F, Trani C, Todaro D, Talarico G, Porto I, Leone AM, Niccoli G, Mazzari MA, Mongiardo R, Schiavoni G, Crea F.
    Minerva Cardioangiol; 2008 Feb 19; 56(1):35-42. PubMed ID: 18432167
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease.
    Minutello RM, Bhagan S, Sharma A, Slotwiner AJ, Feldman DN, Cuomo LJ, Wong SC.
    J Interv Cardiol; 2007 Dec 19; 20(6):458-65. PubMed ID: 18042050
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Outcomes of overlapping bare-metal stents with sirolimus-eluting stents for long lesions in small coronary vessels.
    Kronsteiner E, Lee RW, Sweeney JP, Metallo JR, Stoehr JD, Fortuin FD.
    J Invasive Cardiol; 2010 Feb 19; 22(2):76-9. PubMed ID: 20124593
    [Abstract] [Full Text] [Related]

  • 19. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.
    Morice MC, Serruys PW, Barragan P, Bode C, Van Es GA, Stoll HP, Snead D, Mauri L, Cutlip DE, Sousa E.
    J Am Coll Cardiol; 2007 Oct 02; 50(14):1299-304. PubMed ID: 17903626
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.